PETER HORVATH | Director
CEO, GGB Nevada LLC
Peter Z. Horvath, will serve on the board of directors and serve as the CEO of GGB Nevada LLC. Mr. Horvath currently serves as the chief executive officer of Schottenstein Arviv Group US LLC, doing business as Green Growth Brands, a lifestyle-oriented, consumer products company that celebrates health, wellness and happiness. Mr. Horvath has 35 years of executive management experience with specialty brand retailers such as American Eagle Outfitters, DSW, and Victoria’s Secret Stores at L Brands. From 2012 to 2015, Mr. Horvath served as Chief Executive Officer Mission Essential Personnel, a defense contractor focusing on intelligence solutions. Mr. Horvath received his Bachelor of Business Administration, Business, Management, Marketing, and Related Support Services from Boston University, School of Management.
TIM MOORE | Director
CEO, Xanthic Biopharma Inc.
Over 30 years experience in Fortune 500 leadership roles in Canada and USA. Former President of The Clorox Company of Canada and COO and Synnex Canada. Led Brita North America Consumer and Foodservice water filtration businesses. Experienced with mergers and acquisitions. Progressive positions in Marketing, Sales, Operations and General Management. Has led organizations ranging from start-up to over $1Billion in size. Extensive experience in the launch and growth of premium branded products across a broad range of categories.
David Bhumgara |CPA, CA
CFO, Xanthic Biopharma Inc.
Over 20 years of senior management and capital markets experience, over 15 years of experience as CFO for TSX (Dundee Energy) and TSX.V listed companies in resources, oil and gas, and technology. Extensive experience in finance, accounting, corporate finance, and mergers and acquisitions. Has proven track record working with small to medium size organizations.
GARY GALITSKY | Director
President, Xanthic Biopharma Inc.
Has been producing craft cannabis for designated use for 7 years, proficient in all forms of extraction techniques. One of the earliest applicants to receive the MMAR license for both personal and designated production. Consulted for a number of Licensed Medical Cannabis Producers to develop both scaled plant production growth strategy as well as extraction and secondary processes.